In this article, we discuss the 13 Oversold Value Stocks to Invest in Now.
Amid Wall Street’s latest pullback, opportunities have emerged beyond the high-priced tech companies that have dominated the market in 2025. On August 20, 2025, both the Nasdaq and S&P 500 fell, driven by a reduction in investor positions in richly valued technology stocks ahead of Federal Reserve Chair Jerome Powell’s speech at Jackson Hole. While the S&P 500 tech index closed the day lower, more defensive and value-focused stocks, including energy, healthcare, and consumer staples, ended the day higher.
Analysts see the move not as a massive selloff, but as a strategic shift in investments. Allspring’s senior portfolio manager, Bryant van Cronkhite, made the following comment:
“A broader lens tells you it’s more of a rotation than a true selloff. Tech valuations look extended in the context of inflated spending today. Number two, I would say that there are a lot of pockets of the market that look very attractive from a valuation standpoint and they’ve been broadly ignored.”
This adjustment occurs as investors are becoming increasingly cautious about AI-driven euphoria. Sam Altman, OpenAI’s CEO, warned that AI stocks might be overvalued, indicating a possible bubble. Meanwhile, MIT research shows that most companies see limited short-term returns from AI investments.
With this backdrop, we shift our focus to oversold value stocks, which are trading at appealing valuations, positioned in sectors with stable fundamentals and less hype-driven risk.
Stocks chart
Our Methodology
To curate our list of the 13 Oversold Value Stocks to Invest in Now, we used the Finviz screener to extract a list of stocks with a forward price-to-earnings (P/E) multiple under 15 and with a share price decline of at least 30% on a year-to-date (YTD) basis. Furthermore, we made sure that these stocks displayed a Relative Strength Index (RSI) below 40. Finally, we ranked the stocks in descending order based on the RSI of the respective stocks as of Q1 2025. We also considered the hedge fund sentiment surrounding each stock, using Insider Monkey’s hedge fund database, which tracks over 1,000 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
13. Owens & Minor, Inc. (NYSE:OMI)
Number of Hedge Fund Holders: 31
Forward Price-to-Earnings: 6.41
Relative Strength Index: 37.75
With a price-to-earnings multiple under 15x and its relative strength index below 40, Owens & Minor, Inc. (NYSE:OMI) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
On August 13, 2025, UBS reduced its price target on Owens & Minor, Inc. (NYSE:OMI) from $13 to $7, keeping a ‘Buy’ rating. The price revision follows the company’s weaker Q2 results and a cautious outlook.
Furthermore, the downgrade is associated with the company’s short-term dissynergies from the Patient & Healthcare Services sale and the loss of Kaiser. As a result of these dissynergies, the investment firm expects dampened EBIT for Owens & Minor, Inc. (NYSE:OMI) in 2026.
Yet UBS expects $700 million in potential proceeds from the P&HS sale, which could help Owens & Minor, Inc. (NYSE:OMI) reduce its debt. On the positive side, the analyst highlighted growth catalysts, such as diabetes recovery, sleep therapy momentum, improved capital efficiency, and reduced exposure to struggling hospital purchasing. UBS expects the company to return to profitability in 2025, projecting FY2025 EPS of $1.24.
Through its Products & Healthcare Services and Patient Direct segments, Owens & Minor, Inc. (NYSE:OMI) delivers healthcare solutions globally. It is one of the oversold stocks.
12. Align Technology, Inc. (NASDAQ:ALGN)
Number of Hedge Fund Holders: 52
Forward Price-to-Earnings: 13.73
Relative Strength Index: 37.74
Align Technology, Inc. (NASDAQ:ALGN) is one of the 13 Oversold Value Stocks to Invest in Now.
Align Technology, Inc. (NASDAQ:ALGN) filed patent infringement lawsuits against Shanghai-based Angelalign Technology for alleged patent violations across the U.S., Europe, and China. The company claims that Angel’s aligner products and software infringe key Align patents, which cover multilayer materials, treatment planning, and advanced aligner features.
Align Technology, Inc. (NASDAQ:ALGN) has invested over $2 billion in R&D since 2001. Thus, it emphasized its commitment to protect innovations that underpin its leadership in digital orthodontics. With this move, the company seeks injunctive relief and damages to safeguard years of investment and ensure fair competition in the rapidly growing global aligner market.
With its Invisalign System, iTero scanners, and exocad software, Align Technology, Inc. (NASDAQ:ALGN) enables digital orthodontic and restorative workflows for patients globally. It is one of the oversold stocks.
11. Lantheus Holdings, Inc. (NASDAQ:LNTH)
Number of Hedge Fund Holders: 43
Forward Price-to-Earnings: 10.79
Relative Strength Index: 32.97
With a price-to-earnings multiple under 15x and its relative strength index below 40, Lantheus Holdings, Inc. (NASDAQ:LNTH) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
Lantheus Holdings, Inc. (NASDAQ:LNTH) announced on August 6, 2025, that the FDA approved a New Drug Application (NDA). This NDA, filed by its affiliate Aphelion, relates to a new formulation of its F 18 PSMA imaging agent. The Prescription Drug User Fee Act (PDUFA) date is set for March 6, 2026.
This development follows the successful launch of PYLARIFY, which is Lantheus Holdings, Inc. (NASDAQ:LNTH)‘s market-leading PSMA PET imaging agent. PSMA has shown an 86% median true-positive rate in recurrent prostate cancer detection.
With the new formulation, Lantheus Holdings, Inc. (NASDAQ:LNTH) expects to boost manufacturing efficiency, increasing batch sizes by roughly 50%, potentially improving patient access and geographic reach. With this development, LNTH takes a step forward in sustainable innovation and advancing prostate cancer imaging.
Lantheus Holdings, Inc. (NASDAQ:LNTH), a radiopharmaceutical-focused company, delivers diagnostic and therapeutic solutions to improve disease detection, treatment, and patient outcomes globally. It is one of the oversold stocks.
10. Kforce Inc. (NYSE:KFRC)
Number of Hedge Fund Holders: 25
Forward Price-to-Earnings: 14.62
Relative Strength Index: 32.27
Kforce Inc. (NYSE:KFRC) is one of the 13 Oversold Value Stocks to Invest in Now.
On July 29, 2025, Truist Securities reduced its price target on Kforce Inc. (NYSE:KFRC) from $50 to $46, maintaining a ‘Hold’ rating. This price revision follows the company’s Q2 earnings release.
During the quarter, Kforce Inc. (NYSE:KFRC)’s top-line and bottom-line results were in line with expectations. However, concerns were raised over the company’s Q3 guidance, which fell short of expectations, projecting a 2% sequential revenue decline versus a 1% decrease in the same period a year ago.
At the same time, Truist highlighted continued client caution as staffing demand has yet to recover. Although Kforce Inc. (NYSE:KFRC) is making efforts to support clients in AI utilization, the investment firm believes that automation remains a structural risk to the industry. Yet the company’s consistent share buybacks and 14 years of uninterrupted dividends bolster investor confidence in the company’s long-term fundamentals.
With its professional staffing solutions in technology and finance, Kforce Inc. (NYSE:KFRC) specializes in IT, data analytics, cloud, and AI-driven services across the U.S. It is one of the oversold stocks.
9. Playtika Holding Corp. (NASDAQ:PLTK)
Number of Hedge Fund Holders: 31
Forward Price-to-Earnings: 6.89
Relative Strength Index: 31.99
With a price-to-earnings multiple under 15x and its relative strength index below 40, Playtika Holding Corp. (NASDAQ:PLTK) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
On August 13, 2025, Bank of America Securities reiterated its ‘Buy’ rating on Playtika Holding Corp. (NASDAQ:PLTK) with a $5.50 price target. This bullish stance remains despite the recent challenges.
In the second quarter, Playtika Holding Corp. (NASDAQ:PLTK)’s legacy portfolio, particularly Slotomania, suffered from declines. However, the company is advancing its efforts to stabilize and revive the title. If that materializes, the company’s performance would experience a boost given PLTK’s strength in the slot category.
Furthermore, Playtika Holding Corp. (NASDAQ:PLTK) is expected to improve its margins, thanks to the expansion of its Direct-to-Consumer business, supported by favorable regulatory conditions. At the same time, the company’s strategic capital allocation, including dividends and possible buybacks, further bolsters investor confidence.
Playtika Holding Corp. (NASDAQ:PLTK) develops and distributes mobile casual and social casino games globally. It is one of the oversold stocks.
8. Globant S.A. (NYSE:GLOB)
Number of Hedge Fund Holders: 31
Forward Price-to-Earnings: 10.99
Relative Strength Index: 31.02
Globant S.A. (NYSE:GLOB) is one of the 13 Oversold Value Stocks to Invest in Now.
On August 14, 2025, Mizuho sharply reduced its price target on Globant S.A. (NYSE:GLOB) from $153 to $91, keeping an ‘Outperform’ rating.
This price revision follows the company’s revised 2025 guidance, projecting constant-currency revenue growth between -1% (excluding acquisitions) and +1%, which is down from the prior 2% forecast. Furthermore, the investment firm highlighted Globant S.A. (NYSE:GLOB)’s longer sales cycles, reduced customer spending, and weaker pipeline conversion across Professional Services, Technology, and Latin America segments. Yet the analyst remains confident in the company’s long-term growth outlook, believing its valuation at roughly 10x 2026 estimated EPS already factors in muted growth expectations.
Leveraging its AI-driven platform, Globant S.A. (NYSE:GLOB) delivers digital transformation and technology services globally, serving industries spanning finance, healthcare, entertainment, travel, and education. It is one of the oversold stocks.
7. Celanese Corporation (NYSE:CE)
Number of Hedge Fund Holders: 41
Forward Price-to-Earnings: 8.34
Relative Strength Index: 30.99
With a price-to-earnings multiple under 15x and its relative strength index below 40, Celanese Corporation (NYSE:CE) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
RBC Capital reduced its price target on Celanese Corporation (NYSE:CE) from $63 to $45 on August 14, 2025, maintaining a ‘Sector Perform’ rating.
The investment firm attributed its target cut to weak volumes, production issues, and soft demand in autos and tow markets. Accordingly, the analyst projects a 24% YoY decline in the company’s Q3 earnings.
While several analysts have revised earnings downward, Celanese Corporation (NYSE:CE) is still expected to deliver profitability in 2025. Thanks to cost reductions of $120 million in FY25 and $50-100 million in FY26, the company projects $2 per share quarterly earnings. However, the investment firm reduced EBITDA forecasts to $500 million for Q3 and $1.9 billion for the full year. Thus, RBC Capital projects limited short-term upside until demand stabilizes.
Celanese Corporation (NYSE:CE), a producer of engineered polymers and specialty materials, serves automotive, medical, industrial, and consumer applications globally. It is one of the oversold stocks.
6. Unity Group LLC (NASDAQ:UNIT)
Number of Hedge Fund Holders: 31
Forward Price-to-Earnings: 11.86
Relative Strength Index: 30.45
Unity Group LLC (NASDAQ:UNIT) is one of the 13 Oversold Value Stocks to Invest in Now.
BofA Securities reaffirmed its ‘Underperform’ rating on Unity Group LLC (NASDAQ:UNIT) on August 7, 2025. Yet the analyst raised its price target from $3.50 to $7.50, indicating a slight upside.
The price revision by the investment firm reflects an 8x multiple on Unity Group LLC (NASDAQ:UNIT)’s 2026 estimated adjusted EBITDA of $1.3 billion. This higher target reflects the company’s growing fiber broadband market share, supported by investor interest in fiber assets. Meanwhile, despite the company’s healthy liquidity, the analyst raised concerns over the company’s pro forma adjusted EBITDA, which stands at $1.5 billion against $8.3 billion in net debt, implying 5.5x leverage.
Although Unity Group LLC (NASDAQ:UNIT) is well-positioned to accelerate its fiber build and tap Hyperscaler demand, its high leverage tempers its growth expectations.
Through its Wholesale, Enterprise, and Fiber Solutions segments, Unity Group LLC (NASDAQ:UNIT) delivers fiber-based connectivity solutions across the U.S. It is one of the oversold stocks.
5. Alight, Inc. (NYSE:ALIT)
Number of Hedge Fund Holders: 41
Forward Price-to-Earnings: 6.17
Relative Strength Index: 29.63
With a price-to-earnings multiple under 15x and its relative strength index below 40, Alight, Inc. (NYSE:ALIT) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
On August 14, 2025, Alight, Inc. (NYSE:ALIT)’s share price fell to its 52-week low of $3.79, experiencing a 44.25% decline over the past year. This consistent decline is associated with persistent market pressures and increased investor caution. This downward trajectory of the company’s share price comes despite its management’s confidence in the long-term outlook, as demonstrated through its continued share repurchases.
Amid the volatility, three upward revisions to earnings estimates reflect optimism in the company’s ability to stabilize performance. While the analysts believe the stock is in oversold territory, implying a rebound, the company’s future relies on how well it navigates competitive challenges and broader economic uncertainty.
Alight, Inc. (NYSE:ALIT) streamlines workforce management, benefits, and payroll for enterprises globally with its cloud-based human capital and business solutions. It is one of the oversold stocks.
4. FTAI Infrastructure Inc. (NASDAQ:FIP)
Number of Hedge Fund Holders: 24
Forward Price-to-Earnings: 18.9
Relative Strength Index: 29.13
FTAI Infrastructure Inc. (NASDAQ:FIP) is one of the 13 Oversold Value Stocks to Invest in Now.
FTAI Infrastructure Inc. (NASDAQ:FIP) reported its Q2 results on August 7, 2025. The company reported a 44% YoY revenue growth, taking it to $122.3 million. However, revenue missed analyst expectations by 10%. Furthermore, a net loss of $83.9 million was recorded, which missed expectations by 96%.
Meanwhile, during the quarter, FTAI Infrastructure Inc. (NASDAQ:FIP) advanced on strategic fronts. It agreed to acquire the Wheeling & Lake Erie Railway for $1.05 billion, planning to refinance 10.50% senior notes and Series A preferred stock at closing.
Moreover, FTAI Infrastructure Inc. (NASDAQ:FIP) finalized $300 million in tax-exempt financing at Repauno, as its Phase 2 construction progresses. Looking ahead, the company expects an annual revenue growth of 44% over two years, which is above the industry’s 7.9% forecast.
Operating across North America, FTAI Infrastructure Inc. (NASDAQ:FIP) acquires, develops, and operates transportation, energy, and industrial infrastructure assets. It is one of the oversold stocks.
3. Algoma Steel Group Inc. (NASDAQ:ASTL)
Number of Hedge Fund Holders: 33
Forward Price-to-Earnings: 7.83
Relative Strength Index: 27.43
With a price-to-earnings multiple under 15x and its relative strength index below 40, Algoma Steel Group Inc. (NASDAQ:ASTL) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
Moody’s Ratings downgraded Algoma Steel Group Inc. (NASDAQ:ASTL)’s corporate family rating to Caa1 from B3 on August 14, 2025, keeping a negative outlook. This downgrade follows the company’s weak operating results, heavy cash burn, and risks from U.S. steel tariffs.
Furthermore, the agency also downgraded Algoma Steel Group Inc. (NASDAQ:ASTL)’s senior secured second lien notes from B3 to Caa1 and its speculative-grade liquidity rating from SGL-2 to SGL-4. Looking ahead, Moody’s expects negative EBITDA through fiscal 2026, implying a liquidity crunch for the company. This expectation arises despite ASTL’s $360.57 million loan application under Canada’s Large Enterprise Tariff Loan program. While government support could ease the situation for the company, higher leverage, tariff pressures, and execution risks associated with its Electric Arc Furnace project continue to temper credit quality.
Algoma Steel Group Inc. (NASDAQ:ASTL) manufactures and sells flat and plate steel products, serving automotive, construction, energy, and industrial markets in North America and the rest of the world. It is one of the oversold stocks.
2. Haemonetics Corporation (NYSE:HAE)
Number of Hedge Fund Holders: 35
Forward Price-to-Earnings: 10.69
Relative Strength Index: 24.72
Haemonetics Corporation (NYSE:HAE) is one of the 13 Oversold Value Stocks to Invest in Now.
On August 14, 2025, Mizuho reduced its price target on Haemonetics Corporation (NYSE:HAE) from $90 to $70, maintaining an ‘Outperform’ rating. This price revision follows the company’s fiscal Q1 results.
For Q1, Haemonetics Corporation (NYSE:HAE) reported a $20 million revenue beat, alongside earnings that surpassed estimates by $0.09 per share. The company’s robust performance was driven by strong Plasma and Blood Center results. However, its share price declined 26% amid concerns over slowing growth in the VASCADE MVP product line. The VASCADE MVP segment decelerated to 6% from 28% last quarter. Furthermore, Mizuho highlighted the company’s leadership strategy shifts and competitive pressures, citing them as key concerns. Looking ahead, the analyst expects recovery to take at least six months.
Haemonetics Corporation (NYSE:HAE), a global medical technology firm, delivers plasma collection systems, donor management software, and advanced hospital solutions, including electrophysiology, trauma, surgery, and critical care. It is one of the oversold stocks.
1. Sabre Corporation (NASDAQ:SABR)
Number of Hedge Fund Holders: 32
Forward Price-to-Earnings: 7.83
Relative Strength Index: 21.67
With a price-to-earnings multiple under 15x and its relative strength index below 40, Sabre Corporation (NASDAQ:SABR) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
Sabre Corporation (NASDAQ:SABR) extended its long-term partnership with oneworld on August 19, 2025. Oneworld is one of the largest global airline alliances. Under this partnership, the company will use the tech firm’s corporate travel data and analytics platform, PRISM. This agreement highlights PRISM as the industry standard, managing over 13 million tickets monthly across 160+ countries and providing insights from 26,000+ corporations.
PRISM helps airlines optimize corporate sales and build smarter offers with its advanced capabilities, including automated peer analysis, contract modeling, and predictive decision science. With the renewal, Sabre Corporation (NASDAQ:SABR) aims to accelerate its vision of personalized, data-driven airline retailing globally.
Sabre Corporation (NASDAQ:SABR), a global technology leader, powers travel retailing, distribution, and fulfillment for airlines, hoteliers, and agencies in over 160 countries. It is one of the oversold stocks.
While we acknowledge the potential of SABR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SABR and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Cheap Value Stocks to Buy Now According to Seth Klarman and 13 Hot Oil Stocks to Buy Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
